ABBEY CHRISTENSEN: Open Payments
NPI 1558820084 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$871 in 30 payments from 13 companies in 2025. Trend: 2023 $1,255 · 2024 $944 · 2025 $871
Food & beverage: $786Education: $85
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $197 |
| ABBVIE INC. | 5 | $114 |
| Lilly USA, LLC | 3 | $86 |
| Janssen Biotech, Inc. | 1 | $85 |
| PFIZER INC. | 3 | $78 |
| Regeneron Healthcare Solutions, Inc. | 2 | $68 |
| LEO Pharma Inc. | 2 | $55 |
| UCB, Inc. | 2 | $49 |
| Novartis Pharmaceuticals Corporation | 2 | $48 |
| E.R. Squibb & Sons, L.L.C. | 2 | $30 |
Products named: DUPIXENT, SKYRIZI, TREMFYA, ADBRY, EBGLYSS, Bimzelx, CIBINQO, TALTZ.
Industry payments across NE — which companies pay providers there.
